You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

EPROSARTAN MESYLATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Eprosartan Mesylate, and what generic alternatives are available?

Eprosartan Mesylate is a drug marketed by Norvium Bioscience and is included in one NDA.

The generic ingredient in EPROSARTAN MESYLATE is eprosartan mesylate. There are eleven drug master file entries for this compound. Additional details are available on the eprosartan mesylate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for EPROSARTAN MESYLATE?
  • What are the global sales for EPROSARTAN MESYLATE?
  • What is Average Wholesale Price for EPROSARTAN MESYLATE?
Summary for EPROSARTAN MESYLATE
Drug patent expirations by year for EPROSARTAN MESYLATE
Recent Clinical Trials for EPROSARTAN MESYLATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Quintiles, Inc.Phase 3
AbbottPhase 3
author! et al. BVPhase 3

See all EPROSARTAN MESYLATE clinical trials

Paragraph IV (Patent) Challenges for EPROSARTAN MESYLATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
TEVETEN Tablets eprosartan mesylate 400 mg and 600 mg 020738 1 2010-05-10

US Patents and Regulatory Information for EPROSARTAN MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Norvium Bioscience EPROSARTAN MESYLATE eprosartan mesylate TABLET;ORAL 202012-001 Nov 16, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience EPROSARTAN MESYLATE eprosartan mesylate TABLET;ORAL 202012-002 Nov 16, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.